Evidence map›Paper›PMID 28837623›Full record

ArticlePloS one2017

Multidimensional pooled shRNA screens in human THP-1 cells identify candidate modulators of macrophage polarization.

Ewa Surdziel, Ieuan Clay, Florian Nigsch, Anke Thiemeyer, Cyril Allard, Gregory Hoffman, John S Reece-Hoyes, Tanushree Phadke, Romain Gambert, Caroline Gubser Keller and 7 more

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Meta-Analysis ofFrontiers in immunology · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Ewa SurdzielNovartis Institutes for Biomedical Research, Basel, Switzerland.
Ieuan ClayNovartis Institutes for Biomedical Research, Basel, Switzerland.
Florian NigschNovartis Institutes for Biomedical Research, Basel, Switzerland.
Anke ThiemeyerNovartis Institutes for Biomedical Research, Basel, Switzerland.
Cyril AllardNovartis Institutes for Biomedical Research, Basel, Switzerland.
Gregory HoffmanNovartis Institutes for Biomedical Research, Cambridge, United States of America.
John S Reece-HoyesNovartis Institutes for Biomedical Research, Cambridge, United States of America.
Tanushree PhadkeNovartis Institutes for Biomedical Research, Cambridge, United States of America.
Romain GambertNovartis Institutes for Biomedical Research, Basel, Switzerland.
Caroline Gubser KellerNovartis Institutes for Biomedical Research, Basel, Switzerland.
Marie-Gabrielle LudwigNovartis Institutes for Biomedical Research, Basel, Switzerland.
Birgit BaumgartenNovartis Institutes for Biomedical Research, Basel, Switzerland.
Mathias FrederiksenNovartis Institutes for Biomedical Research, Basel, Switzerland.
Dirk SchübelerFriedrich Miescher Institute for BioMedical Research, Basel, Switzerland.
Klaus SeuwenNovartis Institutes for Biomedical Research, Basel, Switzerland.
Tewis BouwmeesterNovartis Institutes for Biomedical Research, Basel, Switzerland.
Barna D FodorNovartis Institutes for Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0003-1653-4376
Novartis (Switzerland) · CHNovartis (United States) · USFriedrich Miescher Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are key cell types of the innate immune system regulating host defense, inflammation, tissue homeostasis and cancer. Within this functional spectrum diverse and often opposing phenotypes are displayed which are dictated by environmental clues and depend on highly plastic transcriptional programs. Among these the 'classical' (M1) and 'alternative' (M2) macrophage polarization phenotypes are the best characterized. Understanding macrophage polarization in humans may reveal novel therapeutic intervention possibilities for chronic inflammation, wound healing and cancer. Systematic loss of function screening in human primary macrophages is limited due to lack of robust gene delivery methods and limited sample availability. To overcome these hurdles we developed cell-autonomous assays using the THP-1 cell line allowing genetic screens for human macrophage phenotypes. We screened 648 chromatin and signaling regulators with a pooled shRNA library for M1 and M2 polarization modulators. Validation experiments confirmed the primary screening results and identified OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) as a novel mediator of M2 polarization in human macrophages. Our approach offers a possible avenue to utilize comprehensive genetic tools to identify novel candidate genes regulating macrophage polarization in humans.

Indexed as

Cell Line, TumorCell PolarityHumansMacrophagesModels, BiologicalReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingRNA, Small Interfering

Identifiers

PMID28837623
PMCPMC5570424
OpenAlexW2746941219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.